Company / Working Capital per Share
TG Therapeutics, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$3.06
FY2025
5-year range
$0.80 / $3.14
FY2021-FY2025
Trend
-2.6%
vs FY2024
Sector context
#141 of 210
Health Care
What the data says
At $3.06, TG Therapeutics, Inc.'s working capital per share ranks #141 of 210 in the Health Care sector. Working Capital per Share has fluctuated over the past 10 years, ranging from $0.55 in FY2018 to $4.79 in FY2020.
Based on SEC 10-K filings.
3.06 in FY2025 with a 5-year CAGR of -8.6%.
Improved from $1.80 to $3.06 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +56.2%
- 5-Year CAGR
- -8.6%
- 10-Year CAGR
- -
Sector benchmark
#141 of 210 in Health CareTop 67% of 210This company $3.06 Sector average $146.86
▼
-97.9% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 2.6% year-over-year.
- Ranks #141 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
- Lowest working capital per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.06 | -2.6% |
| FY2024 | $3.14 | +74.0% |
| FY2023 | $1.80 | +124.7% |
| FY2022 | $0.80 | -57.5% |
| FY2021 | $1.89 | -60.6% |
| FY2020 | $4.79 | +521.2% |
| FY2019 | $0.77 | +40.4% |
| FY2018 | $0.55 | -47.8% |
| FY2017 | $1.05 | +52.0% |
| FY2016 | $0.69 | -58.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026